Faraday Pharmaceuticals to Attend Jefferies London Conference
06 Nov 2024 //
GLOBENEWSWIRE
Faraday Pharma To Host KOL Webinar On Ischemia-Reperfusion Injury
16 Jul 2024 //
GLOBENEWSWIRE
Faraday Announces Completion of Enroll in Pivotal Ph3 Iocyte AMI-3 of FDY-5301
11 Jun 2024 //
GLOBENEWSWIRE
Faraday Announces Agreement with FDA on Analysis of Ph 3 IOCYTE AMI-3 Trial Data
04 Jan 2024 //
GLOBENEWSWIRE
Faraday Pharma Announces First Patient Enrolled in Phase 3 Trial for MI
10 May 2022 //
GLOBENEWSWIRE
Faraday to publish Results from Phase 2 Study of FDY-5301
27 Dec 2021 //
GLOBENEWSWIRE